Tianjin Chase Sun Pharmaceutical Co.,Ltd
Tianjin Chase Sun Pharmaceutical Co., Ltd., commonly referred to as Chase Sun, is a prominent player in the pharmaceutical industry, headquartered in Tianjin, China. Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including generic drugs and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in China and beyond, Chase Sun is recognised for its commitment to quality and innovation. The company’s core offerings, which include oncology and cardiovascular medications, stand out due to their rigorous research and development processes. Chase Sun has achieved notable market positioning, underscoring its reputation for excellence in the pharmaceutical sector. As a forward-thinking organisation, it continues to contribute to global health advancements while maintaining a focus on sustainable practices.
DitchCarbon Score
How does Tianjin Chase Sun Pharmaceutical Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianjin Chase Sun Pharmaceutical Co.,Ltd's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianjin Chase Sun Pharmaceutical Co.,Ltd's reported carbon emissions
Tianjin Chase Sun Pharmaceutical Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Tianjin Chase Sun Pharmaceutical aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being called upon to disclose their environmental impact and set ambitious climate goals. In summary, Tianjin Chase Sun Pharmaceutical Co., Ltd has not provided emissions data or climate commitments, indicating a potential area for improvement in their environmental strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tianjin Chase Sun Pharmaceutical Co.,Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
